(© Monkey Business - stock.adobe.com)
In a nutshell
- Exercise releases a protein called CLCF1 that acts like an anti-aging molecule for muscles and bones
- CLCF1 levels naturally decline with age, but resistance training and high-intensity exercise can restore them
- When scientists blocked this protein in mice, exercise lost most of its muscle and bone strengthening benefits
DAEJEON, South Korea — There may really be no better “fountain of youth” remedy than a good old-fashioned workout. Research out of South Korea reveals that when you exercise, your muscles release a powerful protein that acts like a biological time machine, potentially reversing age-related decline in both muscle and bone strength.
Scientists have identified that the molecule cardiotrophin-like cytokine factor 1 (CLCF1) surges through the bloodstream during workouts, particularly resistance training. This protein appears to reverse some aspects of age-related decline. The discovery could explain why some 80-year-olds can outperform sedentary 40-year-olds, and it might lead to new treatments for age-related muscle loss and osteoporosis.
The research, published in Nature Communications, shows that CLCF1 levels naturally decline as we age, but exercise can restore them to youthful levels. When researchers gave this protein to elderly mice, the animals regained muscle strength and bone density that rivaled much younger mice. Even more striking: when scientists blocked the protein’s activity, exercise lost most of its anti-aging benefits.
How Your Muscles Talk to Your Bones During Exercise
CLCF1 belongs to a family of proteins called myokines, which are chemical messengers that muscles release during physical activity. Myokines act like your muscle’s way of sending text messages to the rest of your body about what’s happening during exercise. Some messages tell fat cells to burn more energy, others instruct bones to get stronger, and some even reach your brain to improve mood and memory.
CLCF1 appears especially important because it targets both muscle and bone simultaneously. As we age, both tissues typically weaken together, a process that can lead to frailty, falls, and fractures. One molecule addressing both problems makes it particularly intriguing from a treatment standpoint.
The research team, led by scientists in South Korea, first discovered CLCF1’s importance by analyzing gene activity in muscle samples from people of different ages before and after exercise training. They found that while young people naturally produced plenty of CLCF1 during workouts, older adults made much less of it. Declining CLCF1 levels might be a key reason why exercise becomes less effective at maintaining muscle and bone health as we age.
Laboratory Studies Show Dramatic Results
To test their theory, researchers conducted experiments with both cells in laboratory dishes and live mice. They treated muscle cells with CLCF1 and found that the protein supercharged the cells’ energy production, particularly their ability to burn glucose for fuel. Aging muscles often struggle to efficiently use energy, contributing to weakness and fatigue.
When the team gave CLCF1 injections to 20-month-old mice (roughly equivalent to 80-year-old humans), the results were dramatic. After just two weeks of treatment, the elderly mice showed significant improvements in grip strength and running endurance. Their muscle fibers grew larger, and their bones became denser and stronger.
Muscle analysis revealed that CLCF1 activated several important cellular pathways involved in muscle growth and energy production. The protein particularly boosted glycolysis, which is the process cells use to quickly generate energy from sugar. This helps explain why CLCF1 might be especially important during high-intensity exercise, when muscles need rapid bursts of energy.
CLCF1 also proved to be a powerful bone medicine. The protein worked by suppressing osteoclasts (cells that break down old bone tissue) while promoting osteoblasts, the cells that build new bone. This dual action led to increased bone volume and thickness in the treated mice.
Engineered Mice Reveal Exercise’s Secret
In other experiments, researchers created mice that overproduced CLCF1 throughout their lives. These mice showed enhanced muscle function and stronger bones even without extra exercise. They had better grip strength, could hang from grids longer, and ran farther on treadmills compared to normal mice.
However, the researchers also conducted the opposite experiment: they blocked CLCF1 activity in mice during exercise training. When they gave mice a protein called eCNTFR that neutralizes CLCF1, exercise lost most of its beneficial effects on both muscle and bone. The mice could still run on treadmills, but they didn’t gain the usual improvements in strength, endurance, or bone density.
Simply put, CLCF1 is actually doing much of the heavy lifting when it comes to exercise’s anti-aging benefits.
Human Evidence Points to Similar Effects
The mouse studies were impressive, but do these results apply to humans? The researchers examined blood samples from people of various ages and exercise habits to find out. They discovered that circulating CLCF1 levels naturally decline with age in humans, just as they do in mice.
However, exercise could reverse this decline. When young adults performed resistance training or high-intensity interval workouts, their blood CLCF1 levels increased significantly. Older adults who participated in 12-16 week resistance training programs also saw their CLCF1 levels rise, though the response was somewhat reduced compared to younger people.
Different types of exercise produced different responses. Resistance training and high-intensity intervals boosted CLCF1 levels, but moderate-intensity aerobic exercise (like casual treadmill walking) did not. CLCF1 release might require a certain threshold of exercise intensity.
While these results are exciting, several important limitations should be noted. The human studies involved relatively small groups of participants, and the researchers acknowledge that their human data should be considered “exploratory” and require further investigation. Most of the dramatic anti-aging effects were demonstrated in mice, not humans. While mice are excellent models for studying basic biological processes, findings don’t always translate perfectly to humans.
While we’re still years away from CLCF1-based therapies, these results reinforce the profound importance of staying physically active throughout life. They suggest that resistance training and high-intensity exercise might be particularly powerful tools for healthy aging. For now, the best way to boost your CLCF1 levels is the old-fashioned way: hit the weights, push your limits, and let your muscles work their molecular magic.
Paper Summary
Methodology
Researchers analyzed gene expression data from human muscle samples before and after exercise to identify age-related changes in myokine production. They then conducted laboratory experiments with mouse muscle cells and performed multiple studies with young (3-month-old) and aged (18-24-month-old) mice. Some mice received CLCF1 injections, others had the protein’s activity blocked, and some were genetically modified to overproduce CLCF1. The team measured muscle strength through grip tests and treadmill running, analyzed muscle fiber size through microscopic examination, and assessed bone density using micro-CT scanning. They also collected blood samples from human participants of various ages before and after different exercise programs to measure circulating CLCF1 levels.
Results
CLCF1 levels naturally decline with age in both humans and mice, but exercise training can restore them. In aged mice, CLCF1 treatment improved grip strength, running endurance, muscle fiber size, and bone density. The protein enhanced cellular energy production, particularly glucose metabolism, and activated pathways involved in muscle growth. For bones, CLCF1 suppressed bone-destroying cells while promoting bone-building cells. Mice genetically engineered to overproduce CLCF1 showed enhanced physical performance, while blocking CLCF1 activity eliminated most of exercise’s beneficial effects. In humans, resistance training and high-intensity exercise increased blood CLCF1 levels, but moderate aerobic exercise did not.
Limitations
The human studies involved relatively small sample sizes and should be considered exploratory. Most dramatic anti-aging effects were demonstrated in mice, and findings may not fully translate to humans. The research focused primarily on resistance and high-intensity exercise, leaving questions about other forms of physical activity. Some human cohort baseline CLCF1 levels varied significantly between groups, particularly in elite athletes, which may have influenced results. The muscle-specific knockout experiments showed less pronounced effects than expected, suggesting other cell types may also contribute to CLCF1 production during exercise.
Funding and Disclosures
This research was supported by multiple grants from the National Research Foundation of Korea, the Korea Innovation Foundation, the National Research Council of Science & Technology, and the KRIBB initiative program. The authors declared no competing interests.
Publication Information
This study was published in Nature Communications in 2025, volume 16, article number 4743. The research was conducted by a team led by scientists from the Korea Research Institute of Bioscience and Biotechnology and other institutions in South Korea. The paper was received in June 2024 and accepted in May 2025.